Abstract:Granulocyte‐colony‐stimulating‐factor (G‐CSF) activates signal transducer and activator of transcription 3 (STAT3) by the colony‐stimulating‐factor 3 receptor (CSF3R), then phosphorylated STAT3 enters into nucleus and upregulates suppressor of cytokine signaling 1 (SOCS1) by reorganizing chromatin structure around the SOCS1 locus. Activating SOCS1 prevents T‐cell activationand graft‐versus‐host disease by inhibiting CSF3R, STAT3, and NOD‐, LRR‐ and pyrin domain‐containing protein 3 (NLRP3) inflammasome activation. Graft‐versus‐host disease (GVHD) is a major life‐threatening complication of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Inflammatory signaling pathways promote T‐cell activation and are involved in the pathogenesis of GVHD. Suppressor of cytokine signaling 1 (SOCS1) is a critical negative regulator for several inflammatory cytokines. However, its regulatory role in T‐cell activation and GVHD has not been elucidated. Multiomics analysis of the transcriptome and chromatin structure of granulocyte‐colony‐stimulating‐factor (G‐CSF)‐administered hyporesponsive T cells from healthy donors reveal that G‐CSF upregulates SOCS1 by reorganizing the chromatin structure around the SOCS1 locus. Parallel in vitro and in vivo analyses demonstrate that SOCS1 is critical for restraining T cell activation. Loss of Socs1 in T cells exacerbates GVHD pathogenesis and diminishes the protective role of G‐CSF in GVHD mouse models. Further analysis shows that SOCS1 inhibits T cell activation not only by inhibiting the colony‐stimulating‐factor 3 receptor (CSF3R)/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway, but also by restraining activation of the inflammasome signaling pathway. Moreover, high expression of SOCS1 in T cells from patients correlates with low acute GVHD occurrence after HSCT. Overall, these findings identify that SOCS1 is critical for inhibiting T cell activation and represents a potential target for the attenuation of GVHD.

SOCS3 Expression by Thymic Stromal Cells Is Required for Normal T Cell Development

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis1

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis

Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis.

Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses

Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling.

Relationship Between Suppressor of Cytokine Signaling -3 and Cell Migration and Invasion

Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft‐Versus‐Host Disease

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells.

Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo.

IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3

Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.

The Role of Microtubule-Associated Protein 1s in Socs3 Regulation of Il-6 Signaling

Proline-rich Region in Immune Suppression Protein SOCS3 is Required for Its Biological Functions

Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation

In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response

Regulation of Suppressor of Cytokine Signaling 3 (SOC3) by Growth Hormone in Pro-B Cells

Suppressors of cytokine signaling 3 is essential for FcγR-mediated inflammatory response via enhancing CCAAT/enhancer-binding protein δ transcriptional activity in macrophages

Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity

Suppressor of Cytokine Signaling 3 Inhibits LPS-induced IL-6 Expression in Osteoblasts by Suppressing CCAAT/Enhancer-binding Protein Β Activity